Anglo/Swedish pharmaceutical giant AstraZeneca on Saturday announced a fresh shortfall in planned vaccine shipments to the European Union, citing production problems and export restrictions.
"AstraZeneca is disappointed to announce a shortfall in planned COVID-19 vaccine shipments to the European Union (EU) despite working tirelessly to accelerate supply," it said in a statement.
Copyright © 2012 Naharnet.com. All Rights Reserved. | https://mobile.naharnet.com/stories/en/280103 |